- Symmetry Surgical Inc.
- IntraLase Corp.
- Medtronic CryoCath LP
- NitroMed Inc.
- Boston Scientific Corp.
- Johnson & Johnson
- Guidant Corp.
- Adeza Biomedical Corp.
- Adaltis Inc.
- Serologicals Corp.
- Upstate Group Inc.
- Perrigo Co. PLC
- Perrigo Israel Pharmaceuticals Ltd.
- Life Technologies Corp.
- DNA Research Innovations Ltd.
- Invitrogen China
- GlaxoSmithKline PLC
- Innoviva Inc.
- Sumitomo Dainippon Pharma Co. Ltd.
- Sumitomo Pharmaceuticals Co. Ltd.
- Bayer AG
- Talecris Biotherapeutics Inc.
- ViroPharma Inc.
- Eli Lilly & Co.
- Symmetry Medical nets $123.1mm with IPO
- IntraLase nets $86.8mm with IPO
- CryoCath grosses $Cdn25mm in follow-on offering
- NitroMed nets $81.8mm in FOPO
- Boston Scientific, NitroMed develop NO stents-- concluded
- J&J withdraws offer to acquire Guidant
- Adeza Biomedical nets $62.4mm with IPO
- Adaltis nets $43.35mm with IPO
- Serologicals acquires Upstate Group for $205mm
- Serologicals nets $105.16mm with FOPO
- Perrigo buys Agis Industries for $881mm in cash and stock
- Invitrogen buys DNA Research Innovations for up to $65mm
- Invitrogen acquires Bio Asia for $8mm in cash
- Herbalife completes $211.6mm initial public offering
- Theravance completes $91.5mm IPO
- Dainippon and Sumitomo Pharmaceuticals plan 2005 merger
- Bayer divests its plasma unit to US investors
- ViroPharma takes US rights to Lilly's Vancocin Pulvules
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.